KUBTEC announced today that the US Patent Office has granted the company an additional patent for its technology used for breast specimen imaging using 3-D tomosynthesis.

New research presented at the American Society of Breast Surgeons Annual Conference in Las Vegas indicates that intraoperative use of 3-D specimen tomosynthesis enables breast surgeons and radiologists to significantly reduce their re-excision rates compared to traditional 2-D imaging.

The MOZART® System is in use in Breast Care Centers of Excellence around the world. Come to Kubtec Booth #606 in the exhibition hall to 'Meet a MOZART Expert'. Talk to some of the forward thinking surgeons who use the MOZART 3D imaging specimen system to drive quality of care improvements for their patients.

A study presented at this year’s European Congress of Radiology has concluded that adding digital breast tomosynthesis (DBT) is emerging as promising technology for surgical planning, as it offers a better view of lesion margins than mammography alone, said Dr. Alessia Milan from the University of Turin.

This week we attended the School of Oncoplastic Surgery in Dallas and are grateful to Dr. Gail Lebovic and the School of Oncoplastic Surgery faculty for inviting us to participate. Like them, we at Kubtec share the vision that every woman diagnosed with breast cancer should have the best quality of care during treatment and the best quality of life afterward.

Last week, Kubtec officially commenced operations at their new corporate and manufacturing headquarters in Stratford, Connecticut. Together with Guest of Honor, Connecticut Governor Dannel P. Malloy, Kubtec marked their relocation to larger facilities with an official ribbon-cutting ceremony, performed by Governor Malloy, Vikram Butani, CEO of Kubtec, local Mayor John A. Harkins, and members of the Bridgeport Chamber of Commerce.